Mahidol University: Shock, Septic trials

The registry lists 12 Shock, Septic studies with Mahidol University as lead sponsor. 6 are open to participants now and 0 have results posted.

Phase 2 3Phase 3 1No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Septic Shock Hemodynamic Respond to Volume Resuscitation Versus Vasopressor AdministrationNot yet recruitingNCT07438301
• Human Albumin for Resuscitation in Surgical Septic Shock: A Randomized Controlled Trial (ALBUS Study)Not yet recruitingNCT07212582Phase 3
• Effect of Dynamic Arterial Elastance and Assisted Fluid Management Software Guided Resuscitation in Septic Shock: Pilot StudyRecruitingNCT06937918Not applicable
• Early Versus Conventional Cessation of Hydrocortisone in Septic ShockRecruitingNCT05818826Phase 2
• Terlipressin for Refractory Septic ShockRecruitingNCT04339868Phase 2
• Severe Sepsis/Septic Shock on Admission to the General Surgical ICURecruitingNCT01363635
• CLinical Efficacy of Hemoperfusion With a Cytokine Adsorber in Norepinephrine-Resistant SEptic ShockStatus unknownNCT05136183Not applicable
• Milrinone Versus Placebo in Patients With Septic ShockStatus unknownNCT05122884Phase 2
• Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock PatientsCompletedNCT03344627Not applicable
• Efficacy of HFNC Versus NIV for Prevent Reintubation in Sepsis PatientsCompletedNCT03246893Not applicable
• Early Use of Norepinephrine in Septic Shock ResuscitationCompletedNCT01945983Not applicable
• Efficacy of Hydrocortisone in Treatment of Severe Sepsis/Septic Shock Patients With Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)CompletedNCT01284452Not applicable